Replies to post #33760 on Biotech Values

[lumpy9200]

Dew,

Thank you very much for your enlightening reply. I will listen for any mention of 505b2. Eliminating injections, even if Byetta is the "not so bad" pen type, would be huge. I say "not so bad", but I can only go by what I hear, as I have never experienced a pen injection.

Thanks again, and have great weekend,

Geoff

[Jonathan Robinson]

Dew -

Another consideration would be patent life/protections. Any idea what the patent protection differences would be going BLA vs. 505b2? I assume there could be differences in defense as well as Hatch period. Although I assume the technology patents on formulation might have teeth in such a case. TIA

Jon